Synopsys (SNPS) Stock Still Looks Below Fair Value After a 35% Fall
Synopsys has fallen sharply over the past year, yet its current share price still sends mixed valuation signals as the intrinsic value estimate points to upside while traditional market multiples lean expensive.
- The stock is down 35.1% over the past year, which may reset expectations after a strong multi year run.
- Strong demand for Synopsys tools tied to rising AI related chip complexity can support long term cash generation, while any slowdown in that spending or integration risk from recent acquisitions may pressure what investors are willing to pay.
- The broader checks are mixed rather than clearly cheap or rich, with a value score of 3 and a Discounted Cash Flow (DCF) estimate that sits about 22.4% above the current share price, even as earnings based multiples screen as overvalued.
For investors, the debate is whether Synopsys at around US$392 already reflects the quality of the business or still offers a reasonable entry point based on that intrinsic value estimate.
Scan beyond Synopsys and see how other AI related chip and software plays line up on valuation and quality by reviewing 55 AI infrastructure stocks in the same context.
Is Synopsys Still Cheap on Cash Flow?
The Discounted Cash Flow (DCF) approach here compares Synopsys’ potential future cash generation with today’s share price. The model starts from the latest twelve-month free cash flow of about $2.7 billion and assumes that cash generation continues to grow rather than shrink, which aligns with a business that relies heavily on long contracts and complex AI-related chip design work.
Based on those assumptions, the DCF model arrives at an estimated intrinsic value of about $505 per share, compared with a current price of around $392. This implies that the stock trades roughly 22.4% below that cash flow-based estimate. Recent news of raised full-year guidance, supported by AI-related demand, is consistent with a DCF output that indicates a higher value even after a sharp pullback.
On this cash flow view, Synopsys appears undervalued relative to the intrinsic value implied by these projections for its free cash generation.
Our Discounted Cash Flow (DCF) analysis suggests Synopsys is undervalued by 22.4%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.
Is Synopsys Getting Expensive on Earnings?
The P/E ratio suits Synopsys because most investors frame its value around earnings power from long software contracts and IP licensing. On that measure, the stock trades on about 69.8x earnings, which is more than double the Software industry average of roughly 29.8x and well above the peer group average of 31.5x. That already places Synopsys at a clear premium to many software peers.
The fair P/E ratio implied by the model is about 51.0x, which already bakes in its quality, scale and risk, yet still sits well below the current 69.8x. This gap suggests investors are paying extra for Synopsys exposure compared with what the model suggests for its fundamentals and sector context. Recent strength in results and guidance has supported sentiment, but the numbers here indicate that the stock screens as expensive on earnings.
On a P/E basis, Synopsys appears overvalued, with the current multiple running well ahead of both the tailored fair ratio and sector benchmarks.
See what the numbers say about this price — find out in our valuation breakdown.
The Synopsys Narrative: What Would Justify Today's Price?
Narratives on Simply Wall St take the valuation split around Synopsys and translate it into clear, testable stories about what would need to happen to growth, profitability and earnings for the shares to be worth materially more or materially less than today’s price, all hosted on the Community page.
Each scenario links its number to a specific view on how Synopsys' growth, margins and risk profile might evolve, which gives you something concrete to revisit as new information comes through.
Share a narrative on Synopsys in the Simply Wall St community and present a data-driven case on whether raised guidance tied to AI-related demand really supports today's valuation. Then track how your thesis holds up as new results, deals and industry data arrive.
Do you think there's more to the story for Synopsys? Head over to our Community to see what others are saying!
The Bottom Line
Synopsys screens as undervalued on a Discounted Cash Flow (DCF) view, with the intrinsic value estimate sitting comfortably above the current share price, while the P/E based read still flags the stock as overvalued relative to peers. That split largely reflects a clash between cash flow strength on long contracts and the richer earnings multiple the market is paying for perceived durability and AI exposure.
The crux is whether Synopsys can keep converting its AI related demand and complex chip design work into resilient cash generation that ultimately validates, or eventually narrows, that premium earnings multiple.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com